RAC 0.97% $1.54 race oncology ltd

Ann: Quarterly Activity Report & Appendix 4C, page-3

  1. 426 Posts.
    lightbulb Created with Sketch. 206
    "including completion of the Phase 1B dose escalation stage for the Israel trial" would suggest patient recruitment has been moving along at a decent rate.

    Great work all involved, good luck to all the patients.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.